Ameet Mallik is Chief Executive Officer of ADC Therapeutics SA (ADCT). The company reported total compensation of $2,453,150 for fiscal year 2025.
| Salary | $776,084 |
|---|---|
| Bonus | $0 |
| Stock awards | $1,046,500 |
| Option awards | $0 |
| Non-equity incentive plan | $582,063 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $48,503 |
| Total | $2,453,150 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure ADC Therapeutics SA filed April 20, 2026, accession 0001140361-26-015491.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer | $776,084 | $0 | $1,046,500 | $0 | $582,063 | $0 | $48,503 | $2,453,150 |
| FY2024 | Chief Executive Officer | $746,235 | $621,732 | $0 | $0 | $425,354 | $0 | $44,307 | $1,837,628 |
Totals as disclosed in each year's own compensation disclosure for ADC Therapeutics SA.
| Peer-group chief executive median | $3,525,902 |
|---|---|
| Difference from that median | $-1,072,751 |
| Percentile within the disclosed peer group | 22nd |
| Peers with a disclosed figure | 18 |
Medians and percentiles are computed across the peer group ADC Therapeutics SA discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Ameet Mallik this page | Chief Executive Officer | $2,453,150 |
| Mohamed Zaki | Chief Medical Officer | $1,515,566 |
| Jose Carmona | Chief Financial Officer | $1,247,003 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full ADC Therapeutics SA compensation brief.
Ameet Mallik's compensation sits inside ADC Therapeutics SA's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.